The FDA has approved obecabtagene autoleucel (Aucatzyl) to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Patients with prostate cancer who undergo prostatectomy or radiotherapy have a higher risk of long-term complications than untreated patients with prostate cancer.

Source: Getty Images Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say. The most common immune-related ...

Source: Getty Images Phase 2 trial results support further development of camizestrant for the treatment of estrogen receptor-positive, HER2-negative breast cancer, according to researchers. The ...

Drivers for Uber and Lyft are ferrying patients to cancer care appointments, emergency rooms, kidney dialysis, and other medical visits.

Researchers provided recommendations for managing adverse events in patients with renal cell carcinoma receiving cabozantinib and nivolumab.

Most RCC patients surveyed said telemedicine visits are comparable to in-person visits, but most oncology providers disagreed ...

Belzutifan has a “generally manageable” safety profile in patients with RCC, with a relatively low rate of treatment discontinuation.

Source: Getty Images Avelumab plus axitinib was associated with signifi­cantly longer progression-free survival than ...

Source: Getty Images ASCO-ONS standards for the administration of antineoplastic therapy provide a framework for ensuring ...

Strengthening health care access and quality … will be paramount for improving clinical outcomes and slowing projected trends,” researchers wrote.

ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.